Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon Enhanced Insulin Absorption in T1D
NCT05960565Phase 2Terminated
- Sponsor
- St. Olavs University Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon in type 1 diabetes mellitus (T1D), sponsored by St. Olavs University Hospital. Started Dec 2023; status: terminated.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05960565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05960565.